These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1025 related articles for article (PubMed ID: 9100566)

  • 21. Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition.
    Schweizer R; Martin DD; Schönau E; Ranke MB
    J Clin Endocrinol Metab; 2008 Aug; 93(8):2978-83. PubMed ID: 18505766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intelligence and psychosocial functioning during long-term growth hormone therapy in children born small for gestational age.
    van Pareren YK; Duivenvoorden HJ; Slijper FS; Koot HM; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5295-302. PubMed ID: 15531473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High serum levels of growth hormone (GH) and insulin-like growth factor-I (IGF-I) during high-dose GH treatment in short children born small for gestational age.
    van Dijk M; Mulder P; Houdijk M; Mulder J; Noordam K; Odink RJ; Rongen-Westerlaken C; Voorhoeve P; Waelkens J; Stokvis-Brantsma J; Hokken-Koelega A
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1390-6. PubMed ID: 16464954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced concentration of serum growth hormone-binding protein in children with idiopathic short stature. National Cooperative Growth Study.
    Carlsson LM; Attie KM; Compton PG; Vitangcol RV; Merimee TJ
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1325-30. PubMed ID: 8200933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short children with low birth weight born either small for gestational age or average for gestational age show similar growth response and changes in insulin-like growth factor-1 to growth hormone treatment during the first prepubertal year.
    Ranke MB; Martin DD; Ehehalt S; Schwarze CP; Serra F; Wollmann HA; Schweizer R
    Horm Res Paediatr; 2011; 76(2):104-12. PubMed ID: 21757866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Final height in short children born small for gestational age treated with growth hormone.
    Dahlgren J; Wikland KA;
    Pediatr Res; 2005 Feb; 57(2):216-22. PubMed ID: 15585685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 microg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patients.
    Carrascosa A; Esteban C; Espadero R; Fernández-Cancio M; Andaluz P; Clemente M; Audí L; Wollmann H; Fryklund L; Parodi L;
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3281-6. PubMed ID: 16804042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum free insulin-like growth factor I (IGF-I), total IGF-I, and IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency.
    Kawai N; Kanzaki S; Takano-Watou S; Tada C; Yamanaka Y; Miyata T; Oka M; Seino Y
    J Clin Endocrinol Metab; 1999 Jan; 84(1):82-9. PubMed ID: 9920066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications.
    Muñoz MT; Barrios V; Pozo J; Argente J
    Pediatr Res; 1996 Jun; 39(6):992-8. PubMed ID: 8725260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin sensitivity modulates the growth response during the first year of high-dose growth hormone treatment in short prepubertal children born small for gestational age.
    Gies I; Thomas M; Tenoutasse S; De Waele K; Lebrethon MC; Beckers D; Francois I; Maes M; Rooman R; de Beaufort C; Massa G; De Schepper J
    Horm Res Paediatr; 2012; 78(1):24-30. PubMed ID: 22832126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum growth hormone-binding protein is decreased in prepubertal children with idiopathic short stature.
    Dávila N; Moreira-Andrés M; Alcañiz J; Barceló B
    J Endocrinol Invest; 1996 Jun; 19(6):348-52. PubMed ID: 8844453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced levels of GH during GnRH analogue treatment in pubertal short girls born small for gestational age (SGA).
    van der Kaay DC; Rose SR; van Dijk M; Noordam C; van Rheenen E; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2009 Jun; 70(6):914-9. PubMed ID: 19178519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum levels of growth hormone binding protein in children with normal and precocious puberty: relation to age, gender, body composition and gonadal steroids.
    Juul A; Fisker S; Scheike T; Hertel T; Müller J; Orskov H; Skakkebaek NE
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):165-72. PubMed ID: 10671943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotype: genotype relationships in growth hormone insensitivity syndrome.
    Woods KA; Dastot F; Preece MA; Clark AJ; Postel-Vinay MC; Chatelain PG; Ranke MB; Rosenfeld RG; Amselem S; Savage MO
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3529-35. PubMed ID: 9360502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation.
    Hokken-Koelega AC; Hackeng WH; Stijnen T; Wit JM; de Muinck Keizer-Schrama SM; Drop SL
    J Clin Endocrinol Metab; 1990 Sep; 71(3):688-95. PubMed ID: 2394775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth and growth hormone treatment in short stature children born small for gestational age.
    Labarta JI; Ruiz JA; Molina I; De Arriba A; Mayayo E; Longás AF
    Pediatr Endocrinol Rev; 2009 Feb; 6 Suppl 3():350-7. PubMed ID: 19404234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
    Hokken-Koelega AC; Stijnen T; De Jong MC; Donckerwolcke RA; De Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.